blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3257514

EP3257514 - ANTIDIABETIC EFFECT OF GYPENOSIDE 75 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.12.2020
Database last updated on 04.11.2024
FormerGrant of patent is intended
Status updated on  22.03.2020
FormerRequest for examination was made
Status updated on  17.11.2017
FormerThe international publication has been made
Status updated on  10.11.2017
Formerunknown
Status updated on  21.03.2017
Most recent event   Tooltip11.12.2020Application deemed to be withdrawnpublished on 13.01.2021  [2021/02]
Applicant(s)For all designated states
Intelligent Synthetic Biology Center
401, 291 Daehak-ro
Yuseong-gu
Daejeon 34141 / KR
[2017/51]
Inventor(s)01 / KIM, Sun Chang
401 ho
291 Daehak-ro
Yuseong-gu
Daejeon 34141 / KR
02 / PARK, Chan Bae
107-402
11 Giheung-ro 38beon-gil
Giheung-gu
Yongin-si Gyeonggi-do 16975 / KR
03 / LEE, Soon Jang
4209-1201
62 Gwanggyomaeul-ro
Suji-gu
Yongin-si Gyeonggi-do 16943 / KR
 [2017/52]
Former [2017/51]01 / KIM, Sun Chang
Intelligent Synthetic Biology Center
401, 291 Daehak-ro
Yuseong-gu
Daejeon 34141
Daejeon 34141 / KR
02 / PARK, Chan Bae
107-402, 11, Giheung-ro 38beon-gil
Giheung-gu
Yongin-si
Gyeonggi-do 16975 / KR
03 / LEE, Soon Jang
4209-1201, 62, Gwanggyomaeul-ro
Suji-gu
Yongin-si
Gyeonggi-do16943 / KR
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2017/51]
Application number, filing date16843285.404.05.2016
[2017/51]
WO2016KR04720
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017191856
Date:09.11.2017
Language:KO
[2017/45]
Type: A1 Application with search report 
No.:EP3257514
Date:20.12.2017
Language:EN
[2017/51]
Search report(s)International search report - published on:KR09.11.2017
(Supplementary) European search report - dispatched on:EP22.03.2018
ClassificationIPC:A61K31/704, A23K20/163, A61P3/10, A61P5/50, A23K20/121, A23L33/105
[2020/14]
CPC:
A61K31/704 (EP,US); A23K20/121 (EP); A23K20/163 (US);
A23L33/105 (EP); A61K9/0053 (US); A61P3/10 (EP,US)
Former IPC [2018/17]A61K31/704, A23K20/163, A61P3/10, A61P5/50
Former IPC [2017/51]A61K31/704, A23K20/163
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/51]
TitleGerman:ANTIDIABETISCHE WIRKUNGEN VON GYPENOSID 75[2017/51]
English:ANTIDIABETIC EFFECT OF GYPENOSIDE 75[2017/51]
French:EFFET ANTIDIABÉTIQUE DU GYPÉNOSIDE 75[2017/51]
Entry into regional phase17.03.2017Translation filed 
17.03.2017National basic fee paid 
17.03.2017Search fee paid 
17.03.2017Designation fee(s) paid 
17.03.2017Examination fee paid 
Examination procedure17.03.2017Examination requested  [2017/51]
17.03.2017Date on which the examining division has become responsible
09.10.2018Amendment by applicant (claims and/or description)
23.03.2020Communication of intention to grant the patent
04.08.2020Application deemed to be withdrawn, date of legal effect  [2021/02]
25.08.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2021/02]
Fees paidRenewal fee
19.09.2018Renewal fee patent year 03
16.04.2019Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.05.201803   M06   Fee paid on   19.09.2018
31.05.202005   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP3182123  (INTELLIGENT SYNTHETIC BIOLOGY CT [KR]) [E] 1-4,6-9 * example 1 *;
 [E]EP3181139  (INTELLIGENT SYNTHETIC BIOLOGY CT [KR]) [E] 1-4,6-9 * paragraphs [0035] - [0044]; claim - *;
 [X]  - C Cui ET AL, "E43- Enhanced Production of Gypenoside LXXV Using a Novel Ginsenoside- transforming B-glucosidase from Microbacterium sp. Gsoil 167 and Anti-cancer Activity", Korean Society for Microbiology and Biotechnology 2015 Annual Meeting & International Symposium, (20150624), page 101, URL: http://www.kormb.or.kr/home/kor/data/???????e.pdf, (20170413), XP055364651 [X] 1-4,6-9 * abstract E-43 page 101 *
 [A]  - YOSHIKAWA K ET AL, "STUDIES ON THE CONSTITUENTS OF CUCURBITACEAE PLANTS XVIII. ON THE SAPONIN CONSTITUENTS OF GYNOSTEMMA-PENTAPHYLLUM MAKINO 13", YAKUGAKU ZASSHI, (1987), vol. 107, no. 5, ISSN 0031-6903, pages 361 - 366, XP009504010 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1248/yakushi1947.107.5_361
 [A]  - JIYOUNG YEO ET AL, "Potential Hypoglycemic Effect of an Ethanol Extract of Gynostemma pentaphyllum in C57BL/KsJ- db/db Mice", JOURNAL OF MEDICINAL FOOD, US, (20081201), vol. 11, no. 4, doi:10.1089/jmf.2007.0148, ISSN 1096-620X, pages 709 - 716, XP055458211 [A] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1089/jmf.2007.0148
International search[A]KR20130069430  (CELLTRION INC [KR]) [A] 1-9 * See abstract; and claims 1, 11. *;
 [A]KR20080003931  (TG BIOTECH INC [KR]) [A] 1-9 * See claims 1, 3. *;
 [A]CN103156108  (ZENG XIAOFEI, et al) [A] 1-9 * See abstract; and claim 1. *;
 [E]KR101660834B  (INTELLIGENT SYNTHETIC BIOLOGY CT [KR]) [E] 1-9 * See claims 1-9. *
 [A]  - RAZMOYSKI-NAUMOVSKI, V. et al., "Chemistry and Pharmacology of Gynostemma Pentaphyllum", Phytochemistry Reviews, (20050000), vol. 4, no. 2-3, pages 197 - 219, XP055421982 [A] 1-9 * See abstract; table 1; and page 214, conclusion. *

DOI:   http://dx.doi.org/10.1007/s11101-005-3754-4
 [A]  - HOU, J. -G. et al., "Highly Selective Microbial Transformation of Major Ginsenoside Rb1 to Gypenoside LXXV by Esteya Vermicol a CNU120806", Journal of Applied Microbiology, (20120000), vol. 113, no. 4, pages 807 - 814, XP055364642 [A] 1-9 * See abstract. *

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2012.05400.x
by applicantKR20110020469
    - J BIOL CHEM,, (2003), vol. 278, pages 10436 - 10442
    - INTERNATIONAL HEPATOLOGY COMMUNICATIONS, (1996), vol. 5, pages 289 - 296
    - DIABETES CARE, (1995), vol. 18, no. 6, pages 817 - 824
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.